Gestational Diabetes
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
This systematic review showed that the level of SHBG is significantly lower in GDM pregnant women than that in healthy women.
|
31063851 |
2019 |
Gestational Diabetes
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Transfection of SHBG into insulin-resistant cells may partially improve the level of GLUTs, providing a potential therapeutic approach for the treatment of insulin resistance in GDM.
|
31270755 |
2019 |
Gestational Diabetes
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Multivariate analysis showed that FPG, non-high-density lipoprotein-cholesterol and SHBG are independent predictive factors for GDM.
|
29514404 |
2018 |
Gestational Diabetes
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Decreased SHBG concentrations during the first trimester may predict GDM development.
|
29460646 |
2018 |
Gestational Diabetes
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
According to the results, low SHBG expression not only participates in the development of local insulin resistance, but may also play an important role in PI3K/AKT pathway-mediated systemic insulin resistance and gestational diabetes.
|
29298529 |
2018 |
Gestational Diabetes
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Effect of placental sex hormone-binding globulin single nucleotide polymorphism rs6259 on protein and function in gestational diabetes mellitus.
|
29484425 |
2018 |
Gestational Diabetes
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Logistic regression analysis showed that the preconception insulin under the curve (IAUC) and sex hormone-binding globulin (SHBG) levels were two most significant risk factors for developing GDM (p = 0.014; p = 0.042, respectively).
|
28277120 |
2017 |
Gestational Diabetes
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Circulating concentrations of SHBG represent a potentially useful new biomarker for prediction of risk of GDM beyond the currently established clinical and demographic risk factors.
|
28279160 |
2017 |
Gestational Diabetes
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Means HbA1c and SHBG were compared between glucose-intolerant versus normoglycemic women, and GDM versus no GDM women.
|
27613817 |
2017 |
Gestational Diabetes
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Decreasing expression of SHBG may participate in regulation of insulin signaling, leading to a concomitant decrease in expression of relevant insulin signaling components in placental tissue, implying insulin resistance and eventual development of GDM.
|
27497146 |
2016 |
Gestational Diabetes
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
GDM serum and placental SHBG levels are reduced, hyperinsulinemia may lead to a reduction of SHBG in circulating blood, but also damage the placenta cells which led to placental synthesis and secretion of SHBG decrease.
|
23164471 |
2013 |
Gestational Diabetes
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Compared to the controls, placental tissues from the GDM group displayed significantly decreased immunostaining rates for SHBG, as well as significantly lower levels of SHBG mRNA and protein expression (P<0.05).
|
22098307 |
2011 |
Gestational Diabetes
|
0.100 |
AlteredExpression
|
phenotype |
LHGDN |
Sex hormone binding globulin offers a potential early marker to target women who are at risk for gestational diabetes mellitus.
|
12861158 |
2003 |